These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23684315)

  • 1. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
    Liraz O; Boehm-Cagan A; Michaelson DM
    Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
    Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
    J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade.
    Inbar D; Belinson H; Rosenman H; Michaelson DM
    Neurodegener Dis; 2010; 7(1-3):16-23. PubMed ID: 20160452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.
    Antes R; Ezra-Elia R; Weinberger D; Solomon A; Ofri R; Michaelson DM
    PLoS One; 2013; 8(5):e64949. PubMed ID: 23741431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum.
    Belinson H; Michaelson DM
    J Neural Transm (Vienna); 2009 Nov; 116(11):1427-34. PubMed ID: 19370389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice.
    Dolejší E; Liraz O; Rudajev V; Zimčík P; Doležal V; Michaelson DM
    J Neurochem; 2016 Feb; 136(3):503-9. PubMed ID: 26526158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
    Belinson H; Lev D; Masliah E; Michaelson DM
    J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
    Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
    J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
    Boehm-Cagan A; Michaelson DM
    J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning.
    Har-Paz I; Roisman N; Michaelson DM; Moran A
    J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice.
    Salomon-Zimri S; Boehm-Cagan A; Liraz O; Michaelson DM
    Neurodegener Dis; 2014; 13(2-3):86-92. PubMed ID: 24080852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo.
    Salomon-Zimri S; Koren A; Angel A; Ben-Zur T; Offen D; Michaelson DM
    Curr Alzheimer Res; 2019; 16(4):281-292. PubMed ID: 30819082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo.
    Luz I; Liraz O; Michaelson DM
    Curr Alzheimer Res; 2016 Jun; 13(8):918-29. PubMed ID: 27040139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
    J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.
    Boehm-Cagan A; Bar R; Liraz O; Bielicki JK; Johansson JO; Michaelson DM
    J Alzheimers Dis; 2016 Oct; 54(3):1219-1233. PubMed ID: 27567858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc.
    Harris FM; Brecht WJ; Xu Q; Mahley RW; Huang Y
    J Biol Chem; 2004 Oct; 279(43):44795-801. PubMed ID: 15322121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.